XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Shares Of Common Stock
Accumulated Other Comprehensive Income (Loss)
Dividends declared per share (usd per share) $ 0.25            
Beginning Period Balance at Dec. 31, 2019 $ 4,954,697 $ 1,219 $ 3,306,006 $ 1,652,248 $ (83,434)   $ 78,658
Shares outstanding, beginning balance (shares) at Dec. 31, 2019   119,781,605          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings (1,433,111)     (1,433,111)      
Other comprehensive income - net unrealized gain on securities available-for-sale, net of tax 12,258           12,258
Restricted stock awarded and earned compensation, net of shares forfeited (shares)   194,916          
Restricted stock awarded and earned stock compensation, net of shares forfeited 6,494 $ 2 6,492        
Restricted stock surrendered (shares)   (106,021)       (1,953,711)  
Restricted stock surrendered (3,460)       (3,460)    
Common stock repurchased under Stock Repurchase Program (20)            
Common stock repurchased under Stock Repurchase Program (70,000)   (69,980)        
Cash dividends paid (71,206)   (71,206)        
Ending Period Balance at Mar. 31, 2020 3,390,389 $ 1,201 3,171,312 213,854 (86,894)   90,916
Shares outstanding, ending balance (shares) at Mar. 31, 2020   117,916,789          
Stockholders' Equity Disclosure [Rollforward]              
New Accounting Pronouncement, Effect of Change on Net Income (5,283) [1]     (5,283) [1]     0
Beginning Period Balance at Dec. 31, 2019 4,954,697 $ 1,219 3,306,006 1,652,248 (83,434)   78,658
Shares outstanding, beginning balance (shares) at Dec. 31, 2019   119,781,605          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings (1,399,907)            
Ending Period Balance at Jun. 30, 2020 $ 3,452,898 $ 1,207 3,148,090 247,058 (88,495)   145,038
Shares outstanding, ending balance (shares) at Jun. 30, 2020   118,374,603          
Dividends declared per share (usd per share) $ 0.60            
Beginning Period Balance at Mar. 31, 2020 $ 3,390,389 $ 1,201 3,171,312 213,854 (86,894)   90,916
Shares outstanding, beginning balance (shares) at Mar. 31, 2020   117,916,789          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings 33,204     33,204      
Other comprehensive income - net unrealized gain on securities available-for-sale, net of tax 54,122           54,122
Restricted stock awarded and earned compensation, net of shares forfeited (shares)   550,738          
Restricted stock awarded and earned stock compensation, net of shares forfeited 6,289 $ 6 6,283        
Restricted stock surrendered (shares)   (92,924)          
Restricted stock surrendered (1,601)       (1,601)    
Cash dividends paid (29,505)   (29,505)        
Ending Period Balance at Jun. 30, 2020 $ 3,452,898 $ 1,207 3,148,090 247,058 (88,495)   145,038
Shares outstanding, ending balance (shares) at Jun. 30, 2020   118,374,603          
Dividends declared per share (usd per share) $ 0.25            
Beginning Period Balance at Dec. 31, 2020 $ 3,594,951 $ 1,207 3,100,633 409,391 (88,803)   172,523
Shares outstanding, beginning balance (shares) at Dec. 31, 2020   118,414,853          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings 150,406     150,406      
Other comprehensive income - net unrealized gain on securities available-for-sale, net of tax (66,142)           (66,142)
Restricted stock awarded and earned compensation, net of shares forfeited (shares)   743,444          
Restricted stock awarded and earned stock compensation, net of shares forfeited 6,417 $ 8 6,409        
Restricted stock surrendered (shares)   (52,655)          
Restricted stock surrendered (1,908)       (1,908)    
Cash dividends paid (29,587)   (29,587)        
Ending Period Balance at Mar. 31, 2021 3,654,137 $ 1,215 3,077,455 559,797 (90,711)   106,381
Shares outstanding, ending balance (shares) at Mar. 31, 2021   119,105,642          
Beginning Period Balance at Dec. 31, 2020 3,594,951 $ 1,207 3,100,633 409,391 (88,803)   172,523
Shares outstanding, beginning balance (shares) at Dec. 31, 2020   118,414,853          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings 330,918            
Ending Period Balance at Jun. 30, 2021 $ 3,846,681 $ 1,221 3,056,522 740,309 (96,887)   145,516
Shares outstanding, ending balance (shares) at Jun. 30, 2021   119,555,102          
Dividends declared per share (usd per share) $ 0.25            
Beginning Period Balance at Mar. 31, 2021 $ 3,654,137 $ 1,215 3,077,455 559,797 (90,711)   106,381
Shares outstanding, beginning balance (shares) at Mar. 31, 2021   119,105,642          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings 180,512     180,512      
Other comprehensive income - net unrealized gain on securities available-for-sale, net of tax 39,135           39,135
Restricted stock awarded and earned compensation, net of shares forfeited (shares)   586,271          
Restricted stock awarded and earned stock compensation, net of shares forfeited 8,989 $ 6 8,983        
Restricted stock surrendered (shares)   (136,811)          
Restricted stock surrendered (6,176)       (6,176)    
Cash dividends paid (29,916)   (29,916)        
Ending Period Balance at Jun. 30, 2021 $ 3,846,681 $ 1,221 $ 3,056,522 $ 740,309 $ (96,887)   $ 145,516
Shares outstanding, ending balance (shares) at Jun. 30, 2021   119,555,102          
[1] Impact due to adoption on January 1, 2020 of ASU 2016-13, "Financial Instruments - Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments," and the related amendments, commonly referred to as CECL.